Evidence map›Paper›PMID 35195196›Full record

SynthesisBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2022

Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age.

J Fabião, B Sassi, E F Pedrollo, F Gerchman, C K Kramer, C B Leitão, L C Pinto

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 3 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 3 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Community-engaged COVID-19 contact tracing initiative in Chicago.Journal of clinical and translational science · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

J FabiãoDivisão de Medicina Interna, Hospital Nossa Senhora da Conceição, Porto Alegre, RS, Brasil.ORCID http://orcid.org/0000-0001-6544-871X
B SassiDivisão de Medicina Interna, Hospital Nossa Senhora da Conceição, Porto Alegre, RS, Brasil.ORCID http://orcid.org/0000-0002-2932-6026
E F PedrolloPrograma de Pós-Graduação em Ciências Médicas: Endocrinologia, Divisão de Endocrinologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.ORCID http://orcid.org/0000-0003-3371-2330
F GerchmanPrograma de Pós-Graduação em Ciências Médicas: Endocrinologia, Divisão de Endocrinologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.ORCID http://orcid.org/0000-0001-5873-9498
C K KramerMount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0003-1064-0100
C B LeitãoPrograma de Pós-Graduação em Ciências Médicas: Endocrinologia, Divisão de Endocrinologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.ORCID http://orcid.org/0000-0002-2106-309X
L C PintoDivisão de Medicina Interna, Hospital Nossa Senhora da Conceição, Porto Alegre, RS, Brasil.ORCID http://orcid.org/0000-0003-0954-8622
Universidade Federal do Rio Grande do Sul · BRHospital Nossa Senhora da Conceição · BRMount Sinai Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to study the mechanism behind worse coronavirus disease-19 (COVID-19) outcomes in men and whether the differences between sexes regarding mortality as well as disease severity are influenced by sex hormones. To do so, we used age as a covariate in the meta-regression and subgroup analyses. This was a systematic search and meta-analysis of observational cohorts reporting COVID-19 outcomes. The PubMed (Medline) and Cochrane Library databases were searched. The primary outcome was COVID-19-associated mortality and the secondary outcome was COVID-19 severity. The study was registered at PROSPERO: 42020182924. For mortality, men had a relative risk of 1.36 (95%CI: 1.17 to 1.59; I2 63%, P for heterogeneity <0.01) compared to women. Age was not a significant covariate in meta-analysis heterogeneity (P=0.393) or subgroup analysis. For disease severity, being male was associated with a relative risk of 1.29 (95%CI: 1.19 to 1.40; I2 48%, P for heterogeneity <0.01) compared to the relative risk of women. Again, age did not influence the outcomes of the meta-regression (P=0.914) or subgroup analysis. Men had a higher risk of COVID-19 mortality and severity regardless of age, decreasing the odds of hormonal influences in the described outcomes.

Indexed as

COVID-19FemaleHumansMaleObservational Studies as TopicSARS-CoV-2Severity of Illness Index

Identifiers

PMID35195196
PMCPMC8856598
OpenAlexW4212953840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.